Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Sep;60(3):760–765. doi: 10.1172/JCI108829

Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide.

E Ipp, R E Dobbs, A Arimura, W Vale, V Harris, R H Unger
PMCID: PMC372422  PMID: 330567

Abstract

The effects of glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide upon the release of immunoreactive somatostatin (IRS) from the isolated perfused pancreas were studied. In seven experiments in which glucose was perfused either at a concentration of 100 or 350 mg/dl or at 25 mg/dl, IRS levels were significantly greater at the higher glucose concentrations. In three dose-response experiments in which the perfusing glucose concentration was increased at 30-min intervals from an initial concentration of 25 mg/dl to a final concentration of 300 mg/dl, progressive increases in IRS release were noted at glucose concentrations of 100 mg/dl and above. Perfusion of a 20 mM mixture of 10 amino acids also elicited a prompt and significant biphasic IRS rise in each of six experiments. In five experiments, 20 mM leucine evoked a similar response in mean IRS. Perfusion with 0.075 Ivy U/ml of pancreozymin-cholecystokinin, with or without the presence of a 1 mM 10-amino acid mixture, elicited a prompt rise in IRS with a pattern resembling that of insulin in a total of six experiments. Tolbutamide (0.75 mg/min) also stimulated IRS release in five of six challenges. The IRS responses to nutrients and to pancreozymin and their similarity to the insulin responses raise the possibility that, like insulin, pancreatic somatostatin may have an endocrine role related to nutrient homeostasis.

Full text

PDF
760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimura A., Sato H., Coy D. H., Schally A. V. Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med. 1975 Mar;148(3):784–789. doi: 10.3181/00379727-148-38631. [DOI] [PubMed] [Google Scholar]
  2. Barden N., Alvarado-Urbina G., Côté J. P., Dupont A. Cyclic AMP-dependent stimulation of somatostatin secretion by isolated rat islets of Langerhans. Biochem Biophys Res Commun. 1976 Aug 9;71(3):840–844. doi: 10.1016/0006-291x(76)90907-4. [DOI] [PubMed] [Google Scholar]
  3. Bloom S. R., Mortimer C. H., Thorner M. O., Besser G. M., Hall R., Gomez-Pan A., Roy V. M., Russell R. C., Coy D. H., Kastin A. J. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet. 1974 Nov 9;2(7889):1106–1109. doi: 10.1016/s0140-6736(74)90869-1. [DOI] [PubMed] [Google Scholar]
  4. Bloom S. R., Ralphs D. N., Besser G. M., Hall R., Coy D. H., Kastin A. J., Schally A. V. Proceedings: Effect of somatostatin on motilin levels and gastric emptying. Gut. 1975 Oct;16(10):834–834. [PubMed] [Google Scholar]
  5. Boden G., Sivitz M. C., Owen O. E., Essa-Koumar N., Landor J. H. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science. 1975 Oct 10;190(4210):163–165. doi: 10.1126/science.1166308. [DOI] [PubMed] [Google Scholar]
  6. Creutzfeldt W., Lankisch P. G., Fölsch U. R. Hemmung der Sekretin-und Cholezystokinin-Pankreozymin-induzierten Saft-und Enzymsekretion des Pankreas und der Gallenblasenkontraktion beim Menschen durch Somatostatin. Dtsch Med Wochenschr. 1975 May 16;100(20):1135–1138. [PubMed] [Google Scholar]
  7. Dubois M. P. Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1340–1343. doi: 10.1073/pnas.72.4.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Floyd J. C., Jr, Fajans S. S., Conn J. W., Knopf R. F., Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966 Sep;45(9):1487–1502. doi: 10.1172/JCI105456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iversen J., Miles D. W. Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes. 1971 Jan;20(1):1–9. doi: 10.2337/diab.20.1.1. [DOI] [PubMed] [Google Scholar]
  10. Luft R., Efendic S., Hökfelt T., Johansson O., Arimura A. Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol. 1974 Dec;52(6):428–430. [PubMed] [Google Scholar]
  11. Orci L., Baetens D., Rufener C., Amherdt M., Ravazzola M., Studer P., Malaisse-Lagae F., Unger R. H. Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1338–1342. doi: 10.1073/pnas.73.4.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Pancreatic immunoreactive somatostatin release. Proc Natl Acad Sci U S A. 1977 May;74(5):2140–2143. doi: 10.1073/pnas.74.5.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Response of pancreatic immunoreactive somatostatin to arginine. Life Sci. 1976 Dec 15;19(12):1957–1959. doi: 10.1016/0024-3205(76)90131-4. [DOI] [PubMed] [Google Scholar]
  14. Pelletier G., Leclerc R., Arimura A., Schally A. V. Letter: Immunohistochemical localization of somatostatin in the rat pancreas. J Histochem Cytochem. 1975 Sep;23(9):699–702. doi: 10.1177/23.9.1100709. [DOI] [PubMed] [Google Scholar]
  15. Pointner H., Hengl G., Bayer P. M., Flegel U. Hemmung des postprandialen Triglyzeridanstiegs im Serum durch Somatostatin beim Menschen. Wien Klin Wochenschr. 1977 Apr 1;89(7):224–227. [PubMed] [Google Scholar]
  16. Polak J. M., Pearse A. G., Grimelius L., Bloom S. R. Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet. 1975 May 31;1(7918):1220–1222. doi: 10.1016/s0140-6736(75)92198-4. [DOI] [PubMed] [Google Scholar]
  17. Sakurai H., Dobbs R. E., Unger R. H. The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat. Diabetologia. 1975 Oct;11(5):427–430. doi: 10.1007/BF00429911. [DOI] [PubMed] [Google Scholar]
  18. Schauder P., McIntosh C., Arends J., Arnold R., Frerichs H., Creutzfeldt W. Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett. 1976 Oct 1;68(2):225–227. doi: 10.1016/0014-5793(76)80441-3. [DOI] [PubMed] [Google Scholar]
  19. Unger R. H. Somatostatinoma. N Engl J Med. 1977 Apr 28;296(17):998–1000. doi: 10.1056/NEJM197704282961713. [DOI] [PubMed] [Google Scholar]
  20. Vale W., Ling N., Rivier J., Villarreal J., Rivier C., Douglas C., Brown M. Anatomic and phylogenetic distribution of somatostatin. Metabolism. 1976 Nov;25(11 Suppl 1):1491–1494. doi: 10.1016/s0026-0495(76)80175-8. [DOI] [PubMed] [Google Scholar]
  21. Wahren J. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet. 1976 Dec 4;2(7997):1213–1216. doi: 10.1016/s0140-6736(76)91142-9. [DOI] [PubMed] [Google Scholar]
  22. Wilson R. M., Boden G., Shore L. S., Essa-Koumar N. Effect of somatostatin on meal-stimulated pancreatic exocrine secretions in dogs. Diabetes. 1977 Jan;26(1):7–10. doi: 10.2337/diab.26.1.7. [DOI] [PubMed] [Google Scholar]
  23. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES